Palvella Therapeutics (PVLA) Revenue (QoQ) (2014 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -22.37% |
| Jun 30, 2023 | 935.90% |
| Sep 30, 2022 | -92.56% |
| Jun 30, 2022 | -68.44% |
| Mar 31, 2022 | 121.31% |
| Dec 31, 2021 | 78.40% |
| Sep 30, 2021 | 9.57% |
| Jun 30, 2021 | -80.46% |
| Mar 31, 2021 | 592.59% |
| Dec 31, 2020 | -36.13% |
| Sep 30, 2020 | -73.87% |
| Jun 30, 2020 | -15.19% |
| Mar 31, 2020 | 333.93% |
| Dec 31, 2019 | -79.80% |
| Sep 30, 2019 | 183.80% |
| Jun 30, 2019 | -37.60% |
| Mar 31, 2019 | 1,324.17% |
| Dec 31, 2018 | -92.81% |
| Sep 30, 2018 | -28.62% |
| Jun 30, 2018 | 181.58% |
| Mar 31, 2018 | -77.13% |
| Dec 31, 2017 | 362.24% |
| Sep 30, 2017 | 111.93% |
| Jun 30, 2017 | 37.97% |
| Mar 31, 2017 | -50.74% |
| Dec 31, 2016 | 247.32% |
| Sep 30, 2016 | -26.83% |
| Jun 30, 2016 | -13.94% |
| Mar 31, 2016 | 394.52% |
| Dec 31, 2015 | -202.09% |
| Sep 30, 2015 | 158.74% |
| Jun 30, 2015 | -26.37% |
| Sep 30, 2014 | -97.32% |